Javascript must be enabled to continue!
Abstract 501: CXCR4 induced ROS accumulation through PI3K/AKT
View through CrossRef
Abstract
Reactive oxygen species (ROS) and oxidative stress have long been implicated in the onset and progression of many cancers. A mechanism by which ROS contributes to cancer is by relaying signals from the cell surface to important signaling proteins, thereby regulating a variety of cellular processes. Identifying the sources of ROS in cancer cells, and the consequences of oxidative stress, remain areas of intense research. We have previously demonstrated that ROS increased expression and activity of the chemokine (CXC) receptor, type 4 (CXCR4), which resulted in trans-endothelial migration of prostate cancer (PCa) cells. Similarly, a study in human hepatoma cells revealed that CXCR4 and its ligand, stromal cell derived factor 1 alpha (SDF-1α), promoted ROS accumulation. We, and others, have demonstrated that increased ROS generation observed in PCa cell lines was largely contributed by the NADPH oxidase (NOX) family of enzymes. ROS accumulation in cells is linked to survival through activation of PI3K/AKT and ERK1/2 pathways. To that end, we’ve demonstrated that phosphorylated AKT (pAKT) expression increased in response to hydrogen peroxide in a dose-dependent manner. Therefore, we sought to investigate whether SDF-1α-mediated regulation of NOX2 enzymes also involved PI3K/AKT signaling. Our results revealed that treatment with the PI3K inhibitor, LY294002, decreased ROS secretion below basal level in the presence of SDF-1α. In contrast, cells treated with the ERK1/2 inhibitor, PD98059, and SDF-1α exhibited increased ROS secretion, suggesting that SDF1α-mediated ROS production did not depend upon ERK1/2 signaling, but was instead, contributed, in part, by PI3K/AKT signaling. To further delineate the involvement of PI3K/AKT in NOX-mediated signaling, we treated cells with apocynin (NOX inhibitor) and assessed its effect on the phosphorylation of AKT. We observed a concomitant decrease in pAKT, in cells where NOX activity was repressed, compared to untreated cells. Likewise, cells, in which NOX activity was inhibited but stimulated by SDF-1α, expressed little pAKT. To determine whether NOX2 and pAKT physically associated in vitro, NOX2 expression was silenced via siRNA transfection, followed by NOX2 immunoprecipitation, prior to Western blot analysis for pAKT protein expression. When compared to untransfected control, cells transfected with NOX2 siRNA alone exhibited decreased expression of pAKT. Finally, stimulation with SDF-1α did not recover expression of pAKT, further validating coordinated efforts between AKT, NOX2 and the SDF-1α/CXCR4 signaling axis. Results generated from this study will further elucidate the mechanism by which CXCR4 promotes oxidative stress through NOX enzymes. Understanding the relationship between known cancer promoting elements, such as CXCR4, ROS, AKT and NOX, will facilitate the development of more comprehensive therapeutics to enhance current clinical strategies to combat cancer metastasis.
Citation Format: Latoya K. Bryant, Kia J. Jones, Cimona V. Hinton. CXCR4 induced ROS accumulation through PI3K/AKT. [abstract]. In: Proceedings of the 105th Annual Meeting of the American Association for Cancer Research; 2014 Apr 5-9; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2014;74(19 Suppl):Abstract nr 501. doi:10.1158/1538-7445.AM2014-501
American Association for Cancer Research (AACR)
Title: Abstract 501: CXCR4 induced ROS accumulation through PI3K/AKT
Description:
Abstract
Reactive oxygen species (ROS) and oxidative stress have long been implicated in the onset and progression of many cancers.
A mechanism by which ROS contributes to cancer is by relaying signals from the cell surface to important signaling proteins, thereby regulating a variety of cellular processes.
Identifying the sources of ROS in cancer cells, and the consequences of oxidative stress, remain areas of intense research.
We have previously demonstrated that ROS increased expression and activity of the chemokine (CXC) receptor, type 4 (CXCR4), which resulted in trans-endothelial migration of prostate cancer (PCa) cells.
Similarly, a study in human hepatoma cells revealed that CXCR4 and its ligand, stromal cell derived factor 1 alpha (SDF-1α), promoted ROS accumulation.
We, and others, have demonstrated that increased ROS generation observed in PCa cell lines was largely contributed by the NADPH oxidase (NOX) family of enzymes.
ROS accumulation in cells is linked to survival through activation of PI3K/AKT and ERK1/2 pathways.
To that end, we’ve demonstrated that phosphorylated AKT (pAKT) expression increased in response to hydrogen peroxide in a dose-dependent manner.
Therefore, we sought to investigate whether SDF-1α-mediated regulation of NOX2 enzymes also involved PI3K/AKT signaling.
Our results revealed that treatment with the PI3K inhibitor, LY294002, decreased ROS secretion below basal level in the presence of SDF-1α.
In contrast, cells treated with the ERK1/2 inhibitor, PD98059, and SDF-1α exhibited increased ROS secretion, suggesting that SDF1α-mediated ROS production did not depend upon ERK1/2 signaling, but was instead, contributed, in part, by PI3K/AKT signaling.
To further delineate the involvement of PI3K/AKT in NOX-mediated signaling, we treated cells with apocynin (NOX inhibitor) and assessed its effect on the phosphorylation of AKT.
We observed a concomitant decrease in pAKT, in cells where NOX activity was repressed, compared to untreated cells.
Likewise, cells, in which NOX activity was inhibited but stimulated by SDF-1α, expressed little pAKT.
To determine whether NOX2 and pAKT physically associated in vitro, NOX2 expression was silenced via siRNA transfection, followed by NOX2 immunoprecipitation, prior to Western blot analysis for pAKT protein expression.
When compared to untransfected control, cells transfected with NOX2 siRNA alone exhibited decreased expression of pAKT.
Finally, stimulation with SDF-1α did not recover expression of pAKT, further validating coordinated efforts between AKT, NOX2 and the SDF-1α/CXCR4 signaling axis.
Results generated from this study will further elucidate the mechanism by which CXCR4 promotes oxidative stress through NOX enzymes.
Understanding the relationship between known cancer promoting elements, such as CXCR4, ROS, AKT and NOX, will facilitate the development of more comprehensive therapeutics to enhance current clinical strategies to combat cancer metastasis.
Citation Format: Latoya K.
Bryant, Kia J.
Jones, Cimona V.
Hinton.
CXCR4 induced ROS accumulation through PI3K/AKT.
[abstract].
In: Proceedings of the 105th Annual Meeting of the American Association for Cancer Research; 2014 Apr 5-9; San Diego, CA.
Philadelphia (PA): AACR; Cancer Res 2014;74(19 Suppl):Abstract nr 501.
doi:10.
1158/1538-7445.
AM2014-501.
Related Results
Abstract 1787: Selective activation of a PI3K catalytic isoform by G protein-coupled receptors in glioblastoma
Abstract 1787: Selective activation of a PI3K catalytic isoform by G protein-coupled receptors in glioblastoma
Abstract
Objective: To determine how PI3K catalytic isoforms become dysregulated in glioblastoma.
Background: Recurrence in glioblastoma (GBM) i...
CXCR4 expression in feline mammary carcinoma cells: evidence of a proliferative role for the SDF-1/CXCR4 axis
CXCR4 expression in feline mammary carcinoma cells: evidence of a proliferative role for the SDF-1/CXCR4 axis
AbstractBackgroundMammary tumours frequently develop in female domestic cats being highly malignant in a large percentage of cases. Chemokines regulate many physiological and patho...
Revision of the genus Aspicera Dahlbom, 1842 (Hym.: Figitidae: Aspicerinae)
Revision of the genus Aspicera Dahlbom, 1842 (Hym.: Figitidae: Aspicerinae)
The genus Aspicera Dahlbom (Hymenoptera: Cynipoidea: Figitidae: Aspicerinae) is revised herein. Aspicera has a Holarctic distribution, being here cited for the first time from the ...
Abstract 4117: AMD070, a novel orally bioavailable CXCR4 inhibitor, inhibits the metastases of oral cancer via SDF-1/CXCR4 system
Abstract 4117: AMD070, a novel orally bioavailable CXCR4 inhibitor, inhibits the metastases of oral cancer via SDF-1/CXCR4 system
Abstract
We have demonstrated that the stromal cell-derived factor (SDF)-1/CXCR4 system is involved in metastatic processes in oral cancer. Moreover, we have also re...
Abstract 1430: CaMKK2 regulates EGF-dependent activation of oncogenic Akt in ovarian cancer cells
Abstract 1430: CaMKK2 regulates EGF-dependent activation of oncogenic Akt in ovarian cancer cells
Abstract
Background-The canonical PI3K/Akt pathway is hyperactive in a variety of cancers including ovarian cancer (OVCa). Using baculovirus-expressed, FPLC-purified...
Demethylation in promoter region of severely damaged hepatocytes enhances chemokine receptor CXCR4 gene expression
Demethylation in promoter region of severely damaged hepatocytes enhances chemokine receptor CXCR4 gene expression
Abstract
The liver is known to possess remarkable regenerative potential, but persistent inflammation or severe acute injury can lead to liver fibrosis and incomplete regen...
Abstract 1133: Glucose deprivation-induced intracellular reactive oxygen species activates the PI3K-AKT axis
Abstract 1133: Glucose deprivation-induced intracellular reactive oxygen species activates the PI3K-AKT axis
Abstract
Glucose is the most efficient energy source and various cancer cells depend on glycolysis for their energy production. On the other hand, tumor microenviron...
Increased Expression of eEF1A2 and PI3K-Akt Signaling Pathway Genes Promotes The Progression of Cervical Cancer
Increased Expression of eEF1A2 and PI3K-Akt Signaling Pathway Genes Promotes The Progression of Cervical Cancer
Abstract
Objective: This study sought to explore the mRNA and protein expression levels of eukaryotic translation elongation factor 1 alpha 2 (eEF1A2) and members of the PI...

